Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asher Mullard

Showing results (1-10 of 681) with videos related to

Pageof 69
Sort By:
Nature Reviews. Drug Discovery|February 11, 2026
2025's FDA approvals by regulatory designationsAsher Mullard
Nature Reviews. Drug Discovery|January 13, 2025
FDA approves next-generation triple therapy for cystic fibrosisAsher Mullard
Nature Reviews. Drug Discovery|January 13, 2025
DLL3 draws two antibody-drug conjugate dealsAsher Mullard
Nature Reviews. Drug Discovery|October 6, 2023
FDA approves fourth JAK inhibitor for myelofibrosisAsher Mullard
Nature Reviews. Drug Discovery|March 11, 2025
Bluebird Bio's cut-price sale highlights challenges for gene therapy fieldAsher Mullard
Nature Reviews. Drug Discovery|March 15, 2025
Wrestling with the RAS cancer drug pipelineAsher Mullard
Nature|January 22, 2025
Cancer cells 'poison' the immune system with tainted mitochondriaAsher Mullard
Nature Reviews. Drug Discovery|August 1, 2015
NCI-MATCH trial pushes cancer umbrella trial paradigmAsher Mullard
Nature Reviews. Drug Discovery|May 4, 2016
US drug spending hits $425 billionAsher Mullard
Nature Reviews. Drug Discovery|July 30, 2016
PARPs pick-upAsher Mullard
Pageof 69

Showing results (1-10 of 681) with videos related to

Sort By:
Pageof 69
Nature Reviews. Drug Discovery|February 11, 2026
2025's FDA approvals by regulatory designationsAsher Mullard
Nature Reviews. Drug Discovery|January 13, 2025
FDA approves next-generation triple therapy for cystic fibrosisAsher Mullard
Nature Reviews. Drug Discovery|January 13, 2025
DLL3 draws two antibody-drug conjugate dealsAsher Mullard
Nature Reviews. Drug Discovery|October 6, 2023
FDA approves fourth JAK inhibitor for myelofibrosisAsher Mullard
Nature Reviews. Drug Discovery|March 11, 2025
Bluebird Bio's cut-price sale highlights challenges for gene therapy fieldAsher Mullard
Nature Reviews. Drug Discovery|March 15, 2025
Wrestling with the RAS cancer drug pipelineAsher Mullard
Nature|January 22, 2025
Cancer cells 'poison' the immune system with tainted mitochondriaAsher Mullard
Nature Reviews. Drug Discovery|August 1, 2015
NCI-MATCH trial pushes cancer umbrella trial paradigmAsher Mullard
Nature Reviews. Drug Discovery|May 4, 2016
US drug spending hits $425 billionAsher Mullard
Nature Reviews. Drug Discovery|July 30, 2016
PARPs pick-upAsher Mullard
Pageof 69